We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Flowserve (FLS) Withdraws Annual View on Coronavirus Concerns
Read MoreHide Full Article
Flowserve Corporation (FLS - Free Report) has withdrawn its earlier announced guidance for 2020 on end-market uncertainties due to the coronavirus pandemic.
The company noted that several of its manufacturing facilities, global technology and engineering centers, quick response centers, and corporate headquarters have suffered temporarily shutdowns, owing to the coronavirus outbreak. However, it remains committed to protect the safety, health and well-being of employees, customers and partners amid the crisis.
Guidance Withdrawn
On the fourth-quarter 2019 conference call held in February, Flowserve had anticipated adjusted earnings of $2.30-$2.45 per share for 2020, suggesting year-over-year growth of 8% at the mid-point.
Also, for the year, the company had expected revenues growth of 3-5%, while net interest expenses were estimated to be $45-$50. Also, the company’s capital expenditure was projected to be $90-$100 million.
However, on uncertainties, regarding the impacts of the outbreak on financial and operating results, Flowserve has now withdrawn its guidance for 2020.
Notably, the duration of the coronavirus pandemic, its geographic spread and the impacts of the governmental regulations imposed in response to the crisis will likely have a bearing on the company’s results. This along with its impacts on the demand for its products and services will likely get reflected in the yearly results.
Bottom Line
The COVID-19 pandemic has dealt a further blow to the manufacturing sector, which was already reeling under the U.S.-China trade tensions and weak global demand. Factory closures across the globe, supply-chain disruptions, low demand for goods and the impacts of the restrictions imposed by several governments, among others, have affected the sector.
There has been a spate of guidance withdrawals by the industry participants lately on account of the volatile situation, arising from the pandemic, and its impact on their performance. Companies such as Barnes Group, Inc. (B - Free Report) , Xylem Inc. (XYL - Free Report) and Stanley Black & Decker, Inc. (SWK - Free Report) have withdrawn their previously announced guidance.
In the past month, the company’s share price has decreased 12.9% compared with the industry’s decline of 14%.
In the past 30 days, the Zacks Consensus Estimate for its earnings has been lowered by 16.3% to $2.01 for 2020 and by 23.3% to $2.07 for 2021.
Today's Best Stocks from Zacks
Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2019, while the S&P 500 gained and impressive +53.6%, five of our strategies returned +65.8%, +97.1%, +118.0%, +175.7% and even +186.7%.
This outperformance has not just been a recent phenomenon. From 2000 – 2019, while the S&P averaged +6.0% per year, our top strategies averaged up to +54.7% per year.
Image: Bigstock
Flowserve (FLS) Withdraws Annual View on Coronavirus Concerns
Flowserve Corporation (FLS - Free Report) has withdrawn its earlier announced guidance for 2020 on end-market uncertainties due to the coronavirus pandemic.
The company noted that several of its manufacturing facilities, global technology and engineering centers, quick response centers, and corporate headquarters have suffered temporarily shutdowns, owing to the coronavirus outbreak. However, it remains committed to protect the safety, health and well-being of employees, customers and partners amid the crisis.
Guidance Withdrawn
On the fourth-quarter 2019 conference call held in February, Flowserve had anticipated adjusted earnings of $2.30-$2.45 per share for 2020, suggesting year-over-year growth of 8% at the mid-point.
Also, for the year, the company had expected revenues growth of 3-5%, while net interest expenses were estimated to be $45-$50. Also, the company’s capital expenditure was projected to be $90-$100 million.
However, on uncertainties, regarding the impacts of the outbreak on financial and operating results, Flowserve has now withdrawn its guidance for 2020.
Notably, the duration of the coronavirus pandemic, its geographic spread and the impacts of the governmental regulations imposed in response to the crisis will likely have a bearing on the company’s results. This along with its impacts on the demand for its products and services will likely get reflected in the yearly results.
Bottom Line
The COVID-19 pandemic has dealt a further blow to the manufacturing sector, which was already reeling under the U.S.-China trade tensions and weak global demand. Factory closures across the globe, supply-chain disruptions, low demand for goods and the impacts of the restrictions imposed by several governments, among others, have affected the sector.
There has been a spate of guidance withdrawals by the industry participants lately on account of the volatile situation, arising from the pandemic, and its impact on their performance. Companies such as Barnes Group, Inc. (B - Free Report) , Xylem Inc. (XYL - Free Report) and Stanley Black & Decker, Inc. (SWK - Free Report) have withdrawn their previously announced guidance.
Zacks Rank, Price Performance and Estimate Trend
Flowserve, with a $3.4-billion market capitalization, currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
In the past month, the company’s share price has decreased 12.9% compared with the industry’s decline of 14%.
In the past 30 days, the Zacks Consensus Estimate for its earnings has been lowered by 16.3% to $2.01 for 2020 and by 23.3% to $2.07 for 2021.
Today's Best Stocks from Zacks
Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2019, while the S&P 500 gained and impressive +53.6%, five of our strategies returned +65.8%, +97.1%, +118.0%, +175.7% and even +186.7%.
This outperformance has not just been a recent phenomenon. From 2000 – 2019, while the S&P averaged +6.0% per year, our top strategies averaged up to +54.7% per year.
See their latest picks free >>